GC/gejc
Clinical trials for GC/gejc explained in plain language.
Never miss a new study
Get alerted when new GC/gejc trials appear
Sign up with your email to follow new studies for GC/gejc, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can adding immunotherapy boost a stomach cancer combo?
Disease control Recruiting nowThis trial is testing whether adding an immunotherapy drug called adebrelimab to a two-drug combination of apatinib and albumin-bound paclitaxel can help people with advanced stomach or gastroesophageal junction cancer. The study enrolls adults whose cancer has progressed after f…
Matched conditions: GC/GEJC
Phase 2 • Sponsor: The First Affiliated Hospital of Zhengzhou University • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
New combo therapy aims to keep stomach cancer from returning after surgery
Disease control Recruiting nowThis study tests whether adding the targeted drug disitamab vedotin to standard chemotherapy (SOX) after surgery can help prevent stomach cancer from coming back in people with HER2-positive stage III disease. About 124 adults who had complete tumor removal with extensive lymph n…
Matched conditions: GC/GEJC
Phase 2 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC